Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy

Area of Science:

• Endocrinology
• Reproductive Medicine
• Thyroidology

Background:

• Primary hypothyroidism requires levothyroxine (L-T4) replacement therapy.
• Pregnancy significantly impacts thyroid hormone metabolism and L-T4 requirements.
• Maintaining euthyroidism is crucial for both maternal and fetal health.

Purpose of the Study:

• To compare the effects of pregnancy on serum free thyroxine (FT4) levels in hypothyroid women.
• To evaluate two different levothyroxine (L-T4) dosing strategies prior to conception.
• To assess the adequacy of maternal thyroid function during early gestation.

Main Methods:

• A prospective study involving 25 women with compensated hypothyroidism anticipating pregnancy.
• Two groups were formed: Group I (14 women) received partially suppressive L-T4 doses, while Group II (11 women) continued their standard substitutive doses.
• Thyroid function tests (FT4, TSH, FT3) were monitored pre-conception and during early gestation.

Main Results:

• Group I demonstrated significantly higher pre-conceptional FT4 and lower TSH levels compared to Group II.
• All women in Group I maintained adequate FT4 levels in early pregnancy.
• Three women in Group II had low-normal FT4, and one had subnormal FT4 levels, indicating a higher frequency of inadequate thyroid hormone levels in this group.

Conclusions:

• Pre-conception adjustment of L-T4 doses to partially suppress TSH levels can ensure adequate maternal FT4 during early pregnancy in women with hypothyroidism.
• This strategy appears safe, cost-effective, and particularly beneficial for thyroidectomized women.
• Optimizing maternal thyroid function preconceptionally may mitigate potential negative impacts on fetal neurodevelopment.